As per the research report, the size of the North America Transfection Reagents and Equipment Market size is valued at USD 266.87 million in 2023. It is estimated to grow at a CAGR of 7.6 % to reach USD 384.91 million by 2028 during the forecast period 2023 to 2028. It is the largest market globally capturing a market share of 30%.
The process which involves the insertion of genetic material, for example, DNA and RNA (double-stranded), into mammalian cells is called transfection. Substances containing the genetic material are called transfection reagents and the equipment is usually used as a delivery mechanism.
Technological advancements occurring in the transfection reagents and equipment market in recent years has addressed the needs of researchers along with biotechnology & biopharmaceutical companies. High-efficiency transfection instruments have entered the market because of these advancements. Further, efficient quantitative and qualitative transfection in a wide range of cells, encompassing the hard-to-transfect cells are also the result of the technological advances.
Alliances worldwide between the pioneering research institutes to trigger drug discovery, technological advancements in transfections, research activities by pharmaceutical and biotechnology companies coupled with augmented research and development spending, an increasing number of cases of cancer and rise in demand for synthetic genes are driving the growth of this market.
Homebrew reagents by researchers, selective effectiveness of transfection reagents as well as the hefty costs of transfection reagents are the primary factors expected to slow down the growth of this market.
This research report segmented and sub-segmented into the following categories:
In 2016, the academic & research institutes category is likely to command the largest market share. Although, the pharmaceutical & biotechnologies category is estimated to grow at the highest CAGR during the aforementioned forecast period.
Presently, North America accounts for the largest market share. The US is the leading market in North America
Companies playing a dominant role in the North America Transfection Reagents and Equipment Market profiled in this report are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). These companies hold a leading position in the transfection reagent and equipment market because of their well-established presence in the fields of genomics, spanning fifty countries, heavy R&D investments, and strong sales as well as distribution force. Other players in the market include Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com